John V. Umstead G1 Therapeutics, Inc. (GTHX) insider trading activity

John V. Umstead is Chief Financial Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 19,331 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

John V. Umstead Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	19,331 Reduced 100.0%	0 Common Stock
Sep 18 2024	SELL Sale (or disposition) back to the issuer	-	168,387 Reduced 89.7%	19,331 Common Stock
Jul 05 2024	SELL Open market or private sale	$1,322 $2.51 p/Share	527 Reduced 0.28%	187,718 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	35,000 Added 15.68%	188,245 Common Stock
May 13 2024	SELL Open market or private sale	$39,043 $4.79 p/Share	8,151 Reduced 5.05%	153,245 Common Stock
Mar 20 2024	BUY Grant, award, or other acquisition	-	37,500 Added 18.85%	161,396 Common Stock
Mar 18 2024	SELL Open market or private sale	$19,771 $3.02 p/Share	6,547 Reduced 5.02%	123,896 Common Stock
Jan 04 2024	SELL Open market or private sale	$326 $2.94 p/Share	111 Reduced 0.09%	130,443 Common Stock
Jan 03 2024	SELL Open market or private sale	$1,971 $3.12 p/Share	632 Reduced 0.48%	130,554 Common Stock
Jan 03 2024	BUY Grant, award, or other acquisition	-	37,300 Added 22.14%	131,186 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	35,000 Added 27.16%	93,886 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	50,000 Added 45.92%	58,886 Common Stock

JVU

John V. Umstead

Chief Financial Officer

Research Triangle Park, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Value

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

Operation

Value

Type

News

Receive news related to G1 Therapeutics, Inc.

Track Activities on GTHX

Account